Earnings estimate | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
---|---|---|---|---|
No. of analysts | 3 | 3 | 3 | 2 |
Avg. Estimate | 0.02 | 0.06 | 0.21 | 0.29 |
Low estimate | 0.02 | 0.05 | 0.2 | 0.28 |
High estimate | 0.03 | 0.07 | 0.23 | 0.3 |
Year ago EPS | 0.06 | 0.04 | 0.14 | 0.21 |
Revenue estimate | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
---|---|---|---|---|
No. of analysts | 3 | 3 | 3 | 2 |
Avg. Estimate | 25.79M | 29.1M | 114.87M | 125.55M |
Low estimate | 25.6M | 28M | 114M | 125.1M |
High estimate | 26M | 29.91M | 116.6M | 126M |
Year ago sales | 29.98M | N/A | 112.25M | 114.87M |
Sales growth (year/est) | -14.00% | N/A | 2.30% | 9.30% |
Earnings history | 30/03/2023 | 29/06/2023 | 29/09/2023 | 30/12/2023 |
---|---|---|---|---|
Est. EPS | 0.05 | 0.06 | 0.04 | 0.05 |
Actual EPS | 0.06 | 0.04 | 0.01 | 0.04 |
Difference | 0.01 | -0.02 | -0.03 | -0.01 |
Surprise % | 20.00% | -33.30% | -75.00% | -20.00% |
EPS trend | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
---|---|---|---|---|
Current estimate | 0.02 | 0.06 | 0.21 | 0.29 |
7 days ago | 0.02 | 0.06 | 0.21 | 0.29 |
30 days ago | 0.04 | 0.07 | 0.25 | 0.35 |
60 days ago | 0.04 | 0.07 | 0.25 | 0.35 |
90 days ago | 0.04 | 0.07 | 0.25 | 0.35 |
EPS revisions | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
---|---|---|---|---|
Up last 7 days | N/A | N/A | N/A | N/A |
Up last 30 days | N/A | N/A | N/A | N/A |
Down last 7 days | N/A | N/A | N/A | N/A |
Down last 30 days | 1 | 1 | 1 | N/A |
Growth estimates | HBIO | Industry | Sector(s) | S&P 500 |
---|---|---|---|---|
Current qtr. | -66.70% | N/A | N/A | N/A |
Next qtr. | 50.00% | N/A | N/A | N/A |
Current year | 50.00% | N/A | N/A | N/A |
Next year | 38.10% | N/A | N/A | N/A |
Next 5 years (per annum) | 10.00% | N/A | N/A | N/A |
Past 5 years (per annum) | -6.95% | N/A | N/A | N/A |